{"id":5046,"date":"2021-05-25T12:08:09","date_gmt":"2021-05-25T10:08:09","guid":{"rendered":"https:\/\/ww2.omceoge.it\/?page_id=5046"},"modified":"2021-05-25T12:11:02","modified_gmt":"2021-05-25T10:11:02","slug":"5046-alisa-prot-n-17916-trasmissione-comunicazioni-aifa-revoca-parziale-divieto-di-utilizzo-medicinali-plasmaderivati-della-ditta-kedrion-spa","status":"publish","type":"post","link":"https:\/\/www.omceoge.it\/home9\/item\/5046-alisa-prot-n-17916-trasmissione-comunicazioni-aifa-revoca-parziale-divieto-di-utilizzo-medicinali-plasmaderivati-della-ditta-kedrion-spa\/","title":{"rendered":"<img src=\"https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png\" class=\"custom-title-icon\" style=\" vertical-align:middle; display:inline-block;\">ALISA &#8211; Prot. n. 17916 &#8211;  Trasmissione comunicazioni AIFA &#8211; REVOCA PARZIALE DIVIETO DI UTILIZZO medicinali plasmaderivati della ditta Kedrion SpA"},"content":{"rendered":"<p>Pubblichiamo la Comunicazione ALISA Prot. 17916<\/p>\n<hr class=\"readMore\">\n<div class=\"allegati_pdf\">\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 17916 &#8211;  Trasmissione comunicazioni AIFA &#8211; REVOCA PARZIALE DIVIETO DI UTILIZZO medicinali plasmaderivati della ditta Kedrion SpA\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/ALISA_17916.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 17916 &#8211;  Trasmissione comunicazioni AIFA &#8211; REVOCA PARZIALE DIVIETO DI UTILIZZO medicinali plasmaderivati della ditta Kedrion SpA\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Comunicazione ALISA<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pubblichiamo la Comunicazione ALISA Prot. 17916<\/p>\n","protected":false},"author":563,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-5046","post","type-post","status-publish","format-standard","hentry","category-notizie-dall-aifa"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/5046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/users\/563"}],"replies":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/comments?post=5046"}],"version-history":[{"count":0,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/5046\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/media?parent=5046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/categories?post=5046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/tags?post=5046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}